- Market Capitalization, $K 5,014,131
- Shares Outstanding, K 30,162
- Annual Sales, $ 12,730 K
- Annual Income, $ -295,160 K
- 60-Month Beta 2.32
- Price/Sales 397.03
- Price/Cash Flow N/A
- Price/Book 7.90
|Period||Period Low||Period High||Performance|
| || |
-7.22 (-4.24%)since 06/17/19
| || |
+7.36 (+4.73%)since 04/17/19
| || |
+16.74 (+11.44%)since 07/17/18
As hemp production increases, Californian legislators have extended the duration of thousands of cannabis cultivation licenses to support the state's thriving industry.
Scott's Miracle Grow's, ADT, Innovative Industrial Properties and GW Pharmaceuticals highlighted as Zacks Bull and Bear of the Day
Is (GWPH) Outperforming Other Medical Stocks This Year?
Cronos (CRON) inks deal to acquire fermentation and manufacturing facility in Winnipeg, Canada, from Apotex Fermentation Inc.
GW Pharmaceuticals PLC (GWPH) closed at $172.45 in the latest trading session, marking a -1.25% move from the prior day.
The recent legalization of marijuana in several states in the US has had many people eager to invest in the emerging sector.
Health Canada issues a non-compliance report on CannTrust (CTST) regarding its greenhouse facility in Pelham, Ontario, which is used for growing cannabis. Shares take a hit.
The Zacks Analyst Blog Highlights: GW, Scotts Miracle-Gro, Cronos, CannTrust and Canopy
Consumer buying habits are shifting, as the cannabis industry evolves. As that happens, investors are being offered incredible opportunities. For example, according to GMP Securities, "demand for extracted...
Several economists and market researchers believe that the four bills may pave the way for marijuana ETFs, which are likely to attract billions of dollars in investment.
|Gw Pharma ADR|
|Nasdaq Composite ETF|
|Nasdaq Biotechnology Ishares ETF|
|Pharmaceutical Vaneck ETF|
|Bldrs Developed Markets 100 ADR Index Fund Inves|
|Bldrs Europe Select ADR Index Fund Invesco|